Insomnia is a disorder of sleeping patterns leading to hitches in falling asleep at night, waking up in the middle of it and being unable to go back to sleep again. It is an extensive health concern that is responsible for diminished life quality and swelling costs of health care.
Insomnia clinical trials are studies conducted based on the most favourable models which club together pharmacological and behavioural therapies for managing insomnia clinically. The following steps are needed to participate in insomnia clinical trials –
- The first step in participating in insomnia clinical trials is to fill out the registration form for an upcoming trial and check whether one qualifies for an upcoming trial.
- If you are screened for a trial, then the next step would be going to a physician for a complete assessment of your bodily conditions.
- The medications that are received keeping in mind the results of medical evaluations are completely cost-free.
- A volunteer is also paid remuneration and reimbursement for any travelling charges or costs involved in participating in the trials.
- It gives an individual to become a vanguard of modern medical experiments and research and have knowledge about future opportunities.
Who all can participate?
- The length of insomnia trials can last up to several weeks.
- Anyone that lies in the age group of 20 to 84 years is eligible to participate in the trials during the time of seeking their formal consent.
- Individuals who have been diagnosed with insomnia of the following types: physical or psychiatric insomnia, Japanese version (DSM-IV-TR) insomnia or mental disorder insomnia.
Who all cannot participate?
- Individuals who have insomnia caused due to intake of drugs, i.e. pharmacologically induced cannot participate in insomnia clinical trials.
- Individuals who have diseases like PSTD, drug abuse, suicide risks, alcohol abuse, anorexia, personality disorder.
- Individuals who have sleep disorders that are not insomnia. This includes restless movements of legs, a disorder in the movement of limbs, disorder of circadian rhythm).
The whole insomnia clinical trial involves four phases –
- Phase 1: The effects of any untimely event like disease or abnormality in the subject are recorded carefully in a CRF (Case Report Form).
- Phase2: In this phase, people recorded the time they required in order to fall asleep. Median of the data was recorded that encompassed the data of the first day and last day. This data was recorded as the sleep latency parameter.
- Phase 3: Calculating the WASO (Wake Time after Sleep Onset).This includes the total time that includes going to sleep to finally waking up. A median of all data is thus calculated.
- Phase 4: The total number of times a person wakes up intermittently during sleep to the final wakeup time is calculated in this phase.